Trending Biotech Companies
Top gainers and losers in biotech, ranked by market cap performance. Filter by 24-hour, 7-day, or 30-day changes.
Gainers125
Losers71
Best performer+29.51%
| # | Company | Country | 7D Change | Market Cap |
|---|---|---|---|---|
| 1 |  Outlook TherapeuticsOTLK | United States | +29.51% | $204.3M |
| 2 |  Intellia TherapeuticsNTLA | United States | +29.40% | $2.3B |
| 3 |  Nuvectis PharmaNVCT | United States | +29.04% | $376.4M |
| 4 |  ModernaMRNA | United States | +28.15% | $23.8B |
| 5 |  InvivydIVVD | United States | +25.97% | $279.9M |
| 6 |  RezoluteRZLT | United States | +25.50% | $494.5M |
| 7 |  IdorsiaIDIA.SW | Switzerland | +25.11% | $1.8B |
| 8 |  Alpha TeknovaTKNO | United States | +24.76% | $279.3M |
| 9 |  Lixte BiotechnologyLIXT | United States | +22.94% | $132.0M |
| 10 |  Rafael HoldingsRFL | United States | +21.88% | $144.6M |
| 11 |  Rocket PharmaceuticalsRCKT | United States | +21.82% | $381.6M |
| 12 |  PepGenPEPG | United States | +21.77% | $134.2M |
| 13 |  MBX BiosciencesMBX | United States | +21.18% | $2.2B |
| 14 |  Trevi TherapeuticsTRVI | United States | +21.11% | $2.6B |
| 15 |  10X GenomicsTXG | United States | +20.51% | $4.5B |
| 16 |  BiohavenBHVN | United States | +20.30% | $2.3B |
| 17 |  SAB BiotherapeuticsSABS | United States | +20.12% | $304.3M |
| 18 |  Oncolytics BiotechONCY | Canada | +20.00% | $117.3M |
| 19 |  Cognition TherapeuticsCGTX | United States | +19.83% | $154.8M |
| 20 |  MeiraGTxMGTX | United States | +18.04% | $1.1B |
| 21 |  HyperfineHYPR | United States | +17.65% | $158.8M |
| 22 |  OmerosOMER | United States | +17.62% | $735.3M |
| 23 |  Beam TherapeuticsBEAM | United States | +17.60% | $3.7B |
| 24 |  Caliway Biopharmaceuticals6919.TW | Taiwan | +17.58% | $5.9B |
| 25 |  Sana BiotechnologySANA | United States | +17.54% | $972.1M |
| 26 |  Yokogawa6841.T | United States | +17.53% | $8.9B |
| 27 |  REGENXBIORGNX | United States | +17.12% | $458.8M |
| 28 |  Generate BiomedicinesGENB | United States | +17.04% | $2.0B |
| 29 |  Solid BiosciencesSLDB | United States | +16.67% | $805.3M |
| 30 |  Prime MedicinePRME | United States | +16.40% | $619.5M |
| 31 |  PolyPeptide GroupPPGN.SW | Switzerland | +16.25% | $1.6B |
| 32 |  Ginkgo BioworksDNA | United States | +16.22% | $612.1M |
| 33 |  Cue BiopharmaCUE | United States | +16.02% | $125.3M |
| 34 |  Agios PharmaceuticalsAGIO | United States | +15.95% | $2.1B |
| 35 |  Akebia TherapeuticsAKBA | United States | +15.68% | $299.1M |
| 36 |  Alpha CognitionACOG | Canada | +15.36% | $151.8M |
| 37 |  Pyxis OncologyPYXS | United States | +15.34% | $131.5M |
| 38 |  BioAge LabsBIOA | United States | +15.13% | $964.0M |
| 39 |  GenfitGNFT.PA | France | +15.12% | $611.7M |
| 40 |  NyxoahNYXH | Belgium | +15.11% | $158.9M |
| 41 |  Artiva BiotherapeuticsARTV | United States | +14.99% | $485.4M |
| 42 |  Twist BioscienceTWST | United States | +14.95% | $5.4B |
| 43 |  AlectorALEC | United States | +14.38% | $200.4M |
| 44 |  Carbios SASALCRB.PA | France | +13.94% | $118.8M |
| 45 |  Harrow HealthHROW | United States | +13.89% | $1.6B |
| 46 |  VeracyteVCYT | United States | +13.31% | $4.3B |
| 47 |  InflaRxIFRX | Germany | +13.12% | $285.0M |
| 48 |  Nuvation BioNUVB | United States | +13.01% | $2.0B |
| 49 |  UroGen PharmaURGN | United States | +12.95% | $1.7B |
| 50 |  Ultragenyx PharmaceuticalRARE | United States | +12.69% | $2.8B |